SLC5A2 and Glycosuria: To better characterize the genetics of renal glucosuria and its pharmacogenetic impact on antidiabetic medications designed to induce glucosuria, we evaluated SLC5A2 genetics in two large biobanks linked to electronic health record (EHR) data.